NDHnow.com - Drug Updates - New Indications


		Drug Updates \| New Indications

   Web Toolkit
   Drug Updates
       New Drugs
       New Indications
   Patient Teaching

News Capsules

Drug Warnings

Herbal Spotlight

Nursing Links

Career Opportunities

Drug Info Bookstore

Feedback

Registration

Disclaimer

insulin glargine
Lantus SoloStar	Pharmaceutical company: Sanofi-Aventis www.sanofi-aventis.us

NEW INDICATION & DOSAGE
Type 1 or type 2 diabetes--
Adults and children: Initially, 10 international units by subcutaneous injection daily; adjust dosage based on patient response. Dosage range is 2 to 100 international units daily.

Home - Guest Registry - Customer Service